Company record · updated October 7, 2026
Caris Life Sciences Inc: 3 valuation observations from SEC filings
Every row below names the filing it came from. Coverage for this company runs October 31, 2024 to April 30, 2025.
3observations
3source filings
3verified rows
2025-04-30most recent as-of date
Source rails for this company: N-PORT fund mark (3).
Reported by 2 filers: Fidelity Advisor Health Care Fund, Select Health Care Portfolio.
| As of | Measure | Value | Reported by | Tier | What the filing says | Accession |
|---|---|---|---|---|---|---|
| 2025-04-30 | price per share | 1.07 USD | Fidelity Advisor Health Care Fund | VERIFIED | valUSD 1174889.96 / balance 1098028.0 [pp] | 000175272425159806 |
| 2024-11-30 | price per share | 3.18 USD | Select Health Care Portfolio | VERIFIED | valUSD 4517123.22 / balance 1420479.0 [pp] | 000175272425015317 |
| 2024-10-31 | price per share | 3.18 USD | Fidelity Advisor Health Care Fund | VERIFIED | valUSD 3491729.04 / balance 1098028.0 [pp] | 000175272424297782 |
Reading these figures
A fund mark is the filer's own fair-value estimate at a quarter end, not a transaction price, and two filers can reach different values for the same date. A charter round price is the issue price of that series at issuance. Neither is a current market price.